You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Refractory Non-Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Sep 1, 2023

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

Not yet recruiting
  • Non-small Cell Lung Adenocarcinoma
  • Squamous Cell Carcinoma of Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 5, 2023

Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

Not yet recruiting
  • Non-Small-Cell Lung Carcinoma
  • +2 more
  • Liquid biopsy
  • (no location specified)
Jan 24, 2023

Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

Not yet recruiting
  • Lung Adenocarcinoma
  • +3 more
  • Serplulimab and Bevacizumab injection
  • (no location specified)
Dec 21, 2022

ALK-positive NSCLC Trial in Dallas (Ceritinib, Stereotactic ablative body radiation)

Terminated
Has Results
  • ALK-positive Non-small Cell Lung Cancer
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 31, 2023

Real-world Data of Afatinib Treatment in First-line Setting and

Active, not recruiting
  • Non-squamous, Non-Small Cell Lung Cancer
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

The HELPP Score: A Pretreatment Score to Predict Survival in

Not yet recruiting
  • Pancreatic Adenocarcinoma
    • Vienna, Austria
      Department of General Surgery, Division of Visceral Surgery, Med
    Feb 21, 2023

    Cell-Free DNA CHIP for Diagnosing Cancer

    Recruiting
    • Cancer of Pancreas
    • Non-Human Subject Research study.
    • Orlando, Florida
      University of Central Florida
    Nov 20, 2023

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Lung Cancer, Non Small Cell Lung Cancer, Adenocarcinoma of Lung Trial run by the National Cancer Institute (NCI) (LMB-100,

    Active, not recruiting
    • Lung Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 4, 2022

    Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

    Not yet recruiting
    • Adenocarcinoma of Lung
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Jul 8, 2022

    NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • +3 more
    • San Antonio, Texas
    • +1 more
    Sep 8, 2023

    Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

    Not yet recruiting
    • Advanced Solid Tumor
    • +15 more
    • (no location specified)
    Jun 2, 2023

    Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

    Not yet recruiting
    • Solid Tumor
    • +4 more
    • (no location specified)
    Feb 21, 2023

    Colon Cancer, Rectal Cancer, Colon Adenocarcinoma Trial in Seoul (Monofix)

    Completed
    • Colon Cancer
    • +3 more
    • Monofix
    • Seoul, Gangnam, Korea, Republic of
      Samsung Medical Center
    May 14, 2023

    Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)

    Not yet recruiting
    • Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
    • (no location specified)
    Mar 3, 2023

    Lung Adenocarcinoma, Lymph Node Metastasis Trial in Shanghai (Selective Lymph Node Dissection)

    Recruiting
    • Lung Adenocarcinoma
    • Lymph Node Metastasis
    • Selective Lymph Node Dissection
    • Shanghai, Please Select, China
      Chaoqiang Deng
    Sep 4, 2023

    Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +6 more
    • Biopsy
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Adenocarcinoma of the Pancreas, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Lyon (Pembrolizumab,

    Active, not recruiting
    • Adenocarcinoma of the Pancreas
    • +2 more
    • Lyon, France
      Centre Léon Bérard
    Mar 17, 2022